These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 8103763)

  • 41. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of cimetidine and famotidine on esophageal motility].
    Paradowski L; Salomon A; Szelag A
    Pol Tyg Lek; 1996 Apr; 51(14-18):227-9. PubMed ID: 8966165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histamine type 2-receptor antagonists and cancer immunotherapy.
    Smith T
    Compr Ther; 1990 Jan; 16(1):8-13. PubMed ID: 1967999
    [No Abstract]   [Full Text] [Related]  

  • 48. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of H2 blockers and omeprazole on peptic secretion: a prospective, randomized study in duodenal ulcer subjects.
    Di Mario F; Dotto P; Vianello F; Germanà B; Grassi SA; Del Favero G; Faggian D; Plebani M; Naccarato R
    Acta Gastroenterol Belg; 1993; 56(2):223-8. PubMed ID: 8103616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A randomized clinical trial comparing the efficacy of ranitidine and famotidine on intragastric acidity in critically ill pediatric patients.
    Aanpreung P; Vanprapar N; Susiva C; Parkpreaw C; Boonyachart C
    J Med Assoc Thai; 1998 Mar; 81(3):185-9. PubMed ID: 9623009
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bedtime treatment of duodenal ulcer.
    Drug Ther Bull; 1985 Dec; 23(24):95-6. PubMed ID: 2866081
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
    Kumana CR; Ching TY; Cheung E; Kong Y; Kou M; Chan CK; Chu KM; Seto WH; Lam SK
    Clin Pharmacol Ther; 1998 Nov; 64(5):569-74. PubMed ID: 9834050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recurrent parotitis with H2 receptor antagonists in a patient with Sjogren's syndrome.
    Tomasko MA; Luskin AT
    Am J Med; 1988 Aug; 85(2):271. PubMed ID: 2899973
    [No Abstract]   [Full Text] [Related]  

  • 55. Comparison of gastric mucosal surface pH response times after intravenous administration of histamine2-receptor antagonists.
    Katsu K; Yabe S
    Clin Ther; 1995; 17(3):433-10. PubMed ID: 7585847
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
    Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of H2 blockers on the spreading of macrophages in vitro].
    Feder D; Bueno MA; Krybus J; Novak A; Martins MC; Andrade Júnior AF; Cabral M
    Rev Paul Med; 1991; 109(5):213-6. PubMed ID: 1687946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
    Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Restoration of bactericidal activity of peritoneal fluid by cimetidine but not ranitidine or famotidine in burned mice.
    Altaca G; Sayek I; Onat D; Gür D; Akalin E
    Eur J Surg; 1993 Oct; 159(10):551-4. PubMed ID: 8286513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ferrous sulfate does not reduce serum levels of famotidine or cimetidine after concurrent ingestion.
    Partlow ES; Campbell NR; Chan SC; Pap KM; Granberg K; Hasinoff BB
    Clin Pharmacol Ther; 1996 Apr; 59(4):389-93. PubMed ID: 8612382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.